Differential blood DNA methylation across Lewy body dementias
Abstract Introduction Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are characterized by cognitive alterations, visual hallucinations, and motor impairment. Diagnosis is based on type and timing of clinical manifestations; however, determination of clinical subtypes is...
Main Authors: | Chanond A. Nasamran, Anubhav Nikunj Singh Sachan, Jennifer Mott, Yuliya I. Kuras, Clemens R. Scherzer, Harvard Biomarkers Study, Eugenia Ricciardelli, Kristen Jepsen, Steven D. Edland, Kathleen M. Fisch, Paula Desplats |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1002/dad2.12156 |
Similar Items
-
The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
by: Luiza Jadwiga Chwiszczuk, et al.
Published: (2023-05-01) -
Elucidating distinct molecular signatures of Lewy body dementias
by: Joshua Harvey, et al.
Published: (2023-11-01) -
The Cognitive Profile of Mild Cognitive Impairment Due to Dementia With Lewy Bodies—An Updated Review
by: Mathilde Suhr Hemminghyth, et al.
Published: (2020-12-01) -
Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria
by: Joseph R. Phillips, et al.
Published: (2022-11-01) -
Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia
by: Alan J. Thomas, et al.
Published: (2018-03-01)